Literature DB >> 30779984

S-protected gellan gum: Decisive approach towards mucoadhesive antimicrobial vaginal films.

Aamir Jalil1, Mulazim Hussain Asim2, Nguyet-Minh Nguyen Le3, Flavia Laffleur1, Barbara Matuszczak4, Martina Tribus5, Andreas Bernkop-Schnürch6.   

Abstract

The aim of this study was to synthesize novel polymeric excipients forming mucoadhesive films for treatment of vaginal microbial infections. 2-(2-Amino ethyldisulfanyl) nicotinic acid was conjugated with gellan gum via amide bond formation. The structure of the resulting S-protected gellan gum was confirmed by 1H NMR. S-protected gellan gum variants were characterized for thiol content, cytotoxicity, rheological behaviour and film forming capability. Depending on the added amount of AMENA degree of thiolation was 81 ± 13 (S-GG 81) and 174 ± 16 (S-GG 174) μmol/g, respectively. Vaginal films were casted from S-protected gellan gum variants and studied for adherence to vaginal mucosa, drug release and antimicrobial activity. S-protected gellan gum remained biocompatible showing >87% cell viability. S-GG 81 and S-GG 174 exhibited 1.84- and 4.3-fold increased dynamic viscosity in porcine mucus in comparison to unmodified gellan gum, respectively. Compared to gellan gum films, thiol functionalized gellan gum films showed 3-fold improved adhesion on mucosal surface over a period of 3 h along with significant antimicrobial activity. Moreover, S-protected gellan gum provided a sustained release of metronidazole. According to these results, S-protected gellan gum proved to be a promising novel excipient for casting vaginal films, exhibiting strongly improved mucoadhesive and antimicrobial properties.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Metronidazole; Mucoadhesion; Thiolated polymer; Thiomers; Vaginal drug delivery

Mesh:

Substances:

Year:  2019        PMID: 30779984     DOI: 10.1016/j.ijbiomac.2019.02.092

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  7 in total

1.  Per-6-Thiolated Cyclodextrins: A Novel Type of Permeation Enhancing Excipients for BCS Class IV Drugs.

Authors:  Mulazim Hussain Asim; Imran Nazir; Aamir Jalil; Flavia Laffleur; Barbara Matuszczak; Andreas Bernkop-Schnürch
Journal:  ACS Appl Mater Interfaces       Date:  2020-02-06       Impact factor: 9.229

2.  Vaginal Polyelectrolyte Layer-by-Layer Films Based on Chitosan Derivatives and Eudragit® S100 for pH Responsive Release of Tenofovir.

Authors:  Raúl Cazorla-Luna; Araceli Martín-Illana; Fernando Notario-Pérez; Luis Miguel Bedoya; Aitana Tamayo; Roberto Ruiz-Caro; Juan Rubio; María-Dolores Veiga
Journal:  Mar Drugs       Date:  2020-01-09       Impact factor: 5.118

Review 3.  Recent Advances in the Excipients Used in Modified Release Vaginal Formulations.

Authors:  Aikaterini Dedeloudi; Angeliki Siamidi; Panagoula Pavlou; Marilena Vlachou
Journal:  Materials (Basel)       Date:  2022-01-03       Impact factor: 3.623

4.  Synthesis and Characterization of Thiolated Gum Ghatti as a Novel Excipient: Development of Compression-Coated Mucoadhesive Tablets of Domperidone.

Authors:  Vivek Puri; Ameya Sharma; Pradeep Kumar; Inderbir Singh; Kampanart Huanbutta
Journal:  ACS Omega       Date:  2021-06-10

Review 5.  Recent Advances in Polymer-Based Vaginal Drug Delivery Systems.

Authors:  Tomasz Osmałek; Anna Froelich; Barbara Jadach; Adam Tatarek; Piotr Gadziński; Aleksandra Falana; Kinga Gralińska; Michał Ekert; Vinam Puri; Joanna Wrotyńska-Barczyńska; Bozena Michniak-Kohn
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

6.  Chitosan/Poly(2-ethyl-2-oxazoline) Films with Ciprofloxacin for Application in Vaginal Drug Delivery.

Authors:  Guzel K Abilova; Daulet B Kaldybekov; Galiya S Irmukhametova; Diara S Kazybayeva; Zhanar A Iskakbayeva; Sarkyt E Kudaibergenov; Vitaliy V Khutoryanskiy
Journal:  Materials (Basel)       Date:  2020-04-06       Impact factor: 3.623

Review 7.  Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes.

Authors:  Barbara Vigani; Silvia Rossi; Giuseppina Sandri; Maria Cristina Bonferoni; Carla M Caramella; Franca Ferrari
Journal:  Pharmaceutics       Date:  2020-09-10       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.